Closed Drug Transfer Systems to 2022


closed drug transfer systems to 2022   Closed Drug Transfer Systems  • Published December 2016  •  Catalog no. DTS555F  •  Price US $2,850



The administration of drugs deemed hazardous to humans has been receiving increasing amounts of scrutiny in recent years as the dangers of these substances become more clearly understood. For caregivers and their patients, the therapeutic area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites, to treat a wide range of cancers. Regulatory and industry efforts to create standards and procedures designed to protect workers and patients from accidental and incidental exposure to cytotoxics are being driven by data that suggests a causal link between exposure and health issues. Studies of nurses who work with cytotoxic drugs on a regular basis have found a statistically higher rate of spontaneous abortion. Several companies are responding to this unmet need by commercializing devices for closed transfer of these drugs. As the market evolves and user acceptance increases, so too will the impact of these products on oncology therapy protocols and drug delivery

Bar_Graph  Closed Transfer Systems Report Brochure (Download PDF)

Blue document Closed Transfer Systems Report Order Form (Download PDF)


Highlights

· Analyzes the impact of drug toxicity and safety factors on therapeutic oncology market segments, market dynamics and market demographics

· Provides detailed analysis of closed drug transfer products for the handing of cytotoxic drugs

· Analyzes demand drivers and competitive factors influencing closed drug transfer adoption

· Charts product data and provides forecasts to 2022

· Profiles closed drug transfer device participants, their product development activities, business strategies, and corporate alliances and affiliations


Closed Drug Transfer Systems to 2022 – Summary of Contents

Executive Summary

Cytotoxic Drug Therapeutics Market Dynamics

Therapeutic Trends and Issues
The Administration of injectable/Infusible Antineoplastics
Drug Packaging and Administration Technology
Closed Drug Transfer Market Drivers
Competitive Landscape
Risk Factors
Closed Drug Transfer Design Factors

Key System Design Elements
Human Engineering/Ergonomics
Material Selection Issues
Drug Reconstitution and Dilution
Oncology Therapeutics Medication Safety
Oncology Drug Administration and Dosing
Drug-Specific Dosing Modification and Individualized Dosing

Closed Drug Transfer – Commercial Device Assessments

Market Factors

Regulatory Issues
Caregiver Compliance
Level of Complexity and Ease of Use
Healthcare Economics
Business Models and Strategies

Market Assessments and Forecasts

North America
Europe
Asia
Other Geographic Markets

Closed Drug Transfer – Market Participant Profiles


Useful Links

Design Characteristics and Performance Standards